PREVENT ALL ALS Study: An Observational Study for ALS
This is an observational study called PREVENT ALL ALS. It's not testing a specific drug or treatment. Instead, researchers are collecting a wide range of information, samples, and measurements from people with Amyotrophic Lateral Sclerosis (ALS), those who carry an ALS gene, and healthy volunteers. The goal is to gather data that will help future research into ALS and related brain diseases. You might be able to join if you are 18 or older and are a first-degree relative (like a parent, child, or sibling) of someone with a known ALS-causing gene or a strong family history of ALS. The study will track ALS symptoms using a questionnaire over 36 months.
- Study design
- This is an observational study aiming to enroll 600 participants. It is not testing an intervention.
- What's involved
- You would complete an ALS Symptoms Questionnaire at baseline and then every 4 months for 36 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 36 months after baseline.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
PREVENT ALL ALS Study
At a glance
Conditions
NCT06581861
Where you'd take part
This study runs at 32 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Barrow Neurological Institute
Phoenix, Arizonastudy coordinator listed
Recruiting
CHALS-CCT, University of Puerto Rico, Medical Sciences Campus
San Juan, Puerto Rico, Puerto Ricostudy coordinator listed
Recruiting
Columbia University
New York, New Yorkstudy coordinator listed
Recruiting
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshirestudy coordinator listed
Recruiting
Duke University
Durham, North Carolinastudy coordinator listed
Recruiting
Georgetown University
Washington D.C., District of Columbiastudy coordinator listed
Recruiting
Henry Ford Health
Detroit, Michiganstudy coordinator listed
Recruiting
Hospital for Special Care
New Britain, Connecticutstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- ALS Symptoms QuestionnaireBaseline, 4, 8, 12,16,20, 24, 28, 32 and 36 months form baseline
Questions to identify development of symptoms related to ALS